^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    MOR107

    i
    Other names: MOR 107, MOR107, LP2, LP2-3, selective AT2 receptor agonistic lanthipeptide, MOR-107
    Associations
    News
    Trials
    Company:
    Novartis
    Drug class:
    Angiotensin type 2 receptor agonist
    Associations
    News
    Trials